References
- Beckett A. H., Brookes L. G. The absorption and urinary excretion in man of fenfluramine and its main metabolite. J. Pharm. Pharmacol. 1967; 19: 4151. Beckett A. H., Brookes L. G. The absorption and urinary excretion in man of fenfluramine and its main metabolite. J. Pharm. Pharmacol. 1967; 19: 415
- Beckett A. H., Brookes L. G. Administration of two or more related drugs to investigate the effect of molecular modification and formulation on drug absorption, metabolism and excretion. J. Pharm, Pharmacol. 1971; 23: 8372. Beckett A. H., Brookes L. G. Administration of two or more related drugs to investigate the effect of molecular modification and formulation on drug absorption, metabolism and excretion. J. Pharm, Pharmacol. 1971; 23: 837
- Beckett A. H., Moffat A. C. Correlation of partition co-efficients in n-heptane/ aqueous systems with buccal absorption data for series of amines and acids. J. Pharm. Pharmacol. 1969; 21: 44S, Suppl. 13. Beckett A. H., Moffat A. C. Correlation of partition co-efficients in n-heptane/ aqueous systems with buccal absorption data for series of amines and acids. J. Pharm. Pharmacol. 1969; 21: 44S, Suppl. 1
- Beckett A. H., Salmon J. A. Pharmacokinetics of absorption, distribution and elimination of fenfluramine and its main metabolite in man. J. Pharm. Pharmacol. 1972; 24: 1084. Beckett A. H., Salmon J. A. Pharmacokinetics of absorption, distribution and elimination of fenfluramine and its main metabolite in man. J. Pharm. Pharmacol. 1972; 24: 108
- Beckett A. H., Shenoy E. V. B. The effect of N-alkyl chain length and stereochemistry on the absorption, metabolism and urinary excretion of N-alkyl-amphetamines in man. J. Pharm. Pharmacol 1973; 25: 7935. Beckett A. H., Shenoy E. V. B. The effect of N-alkyl chain length and stereochemistry on the absorption, metabolism and urinary excretion of N-alkyl-amphetamines in man. J. Pharm. Pharmacol 1973; 25: 793
- Beckett A. H., Brookes L. G., Shenoy E. V. B. Urinary excretion of the drug and its main metabolite in man, after the adminstration of (±)-, (+)- and (−)-ethylamphetamine. J. Pharm. Pharmacol 1969; 21: 151S, Suppl.6. Beckett A. H., Brookes L. G., Shenoy E. V. B. Urinary excretion of the drug and its main metabolite in man, after the adminstration of (±)-, (+)- and (−)-ethylamphetamine. J. Pharm. Pharmacol 1969; 21: 151S, Suppl.
- Mihailova D., Testa A., Rosen B., Beckett A. H. A pharmacokinetic investigation of the distribution and elimination of diethylpropion and its metabolites in man. J. Pharm. Pharmacol 1974; 26: 7117. Mihailova D., Testa A., Rosen B., Beckett A. H. A pharmacokinetic investigation of the distribution and elimination of diethylpropion and its metabolites in man. J. Pharm. Pharmacol 1974; 26: 711
- Testa B., Beckett A. H. Metabolism and excretion of diethylpropion in man under acidic urine conditions. J. Pharm. Pharmacol 1973; 25: 1198. Testa B., Beckett A. H. Metabolism and excretion of diethylpropion in man under acidic urine conditions. J. Pharm. Pharmacol 1973; 25: 119
- Testa B., Beckett A. H. The metabolism of diethylpropion in man: influence of changes in drug formulation and urinary pH. Pharm. Acta Helv. 1974; 49: 219. Testa B., Beckett A. H. The metabolism of diethylpropion in man: influence of changes in drug formulation and urinary pH. Pharm. Acta Helv. 1974; 49: 21
- Wesley-Hadzija B. The effect of diet in West Africa on pH of human urine. J. Pharm. Pharmacol 1969; 21: 19610. Wesley-Hadzija B. The effect of diet in West Africa on pH of human urine. J. Pharm. Pharmacol 1969; 21: 196